Differential Intraocular Pressure Phacoemulsification
Rohit Om Parkash, Tushya Om Parkash
doaj +1 more source
Intraocular pressure variation (ocular hypertension) in diabetes mellitus. [PDF]
Sinha S +4 more
europepmc +1 more source
Abstract Purpose To evaluate the incidence, outcomes, and risk factors of numerical hypotony (NH) and choroidal effusion (CE) following standalone PRESERFLO MicroShunt (PMS) implantation. Methods Primary open‐angle glaucoma (POAG) and pseudoexfoliative glaucoma (PXG) patients with uni‐ or bilateral surgery at a tertiary university hospital were ...
Emil Nasyrov +5 more
wiley +1 more source
Pseudohypopyon in a Child With Elevated Intraocular Pressure and Progressive Deterioration of Visual Acuity. [PDF]
Miershali M +4 more
europepmc +1 more source
Advances in the genetics of refractive errors: Contributions from the CREAM consortium
Abstract The Consortium for Refractive Error and Myopia (CREAM) was established in 2011, bringing together an international team of researchers studying more than 30 cohorts. Since its establishment, CREAM has played a pivotal role in research investigating the genetics of myopia and other refractive errors, serving as a key driver of progress in the ...
Sze Wai Rosa Li +11 more
wiley +1 more source
Comparison of intraocular pressure measurements with and without fluorescein using Goldmann applanation tonometry. [PDF]
Krešo A +4 more
europepmc +1 more source
Abstract Purpose To determine the long‐term blindness rate and related prognostic factors in eyes with open‐angle glaucoma after trabeculectomy using adjunctive mitomycin C (MMC). Methods The retrospective cohort study included 714 eyes from 714 patients with open angle glaucoma who underwent trabeculectomy using MMC.
Masato Matsuo +5 more
wiley +1 more source
Long-term visual field evaluation of trabeculectomy patients with a mean intraocular pressure below 15 mmHg. [PDF]
Rocha M +9 more
europepmc +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Can intraocular pressure serve as a non-invasive surrogate marker for intracranial pressure following traumatic brain injury? [PDF]
Nguyen BN +13 more
europepmc +1 more source

